RSCI
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jan 16 closing price
Capitalization
N/A
TAK
Price
$12.92
Change
-$0.13 (-1.00%)
Updated
Jan 17 closing price
Capitalization
43.11B
12 days until earnings call
Ad is loading...

RSCI vs TAK

Header iconRSCI vs TAK Comparison
Open Charts RSCI vs TAKBanner chart's image
Redwood Scientific Technologies
Price$0.10
Change-$0.00 (-0.00%)
Volume$320
CapitalizationN/A
Takeda Pharmaceutical
Price$12.92
Change-$0.13 (-1.00%)
Volume$1.4M
Capitalization43.11B
RSCI vs TAK Comparison Chart
Loading...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RSCI vs. TAK commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSCI is a Hold and TAK is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (RSCI: $0.10 vs. TAK: $12.92)
Brand notoriety: RSCI and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RSCI: 11% vs. TAK: 75%
Market capitalization -- RSCI: $0 vs. TAK: $43.11B
RSCI [@Pharmaceuticals: Other] is valued at $0. TAK’s [@Pharmaceuticals: Other] market capitalization is $43.11B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RSCI’s FA Score shows that 0 FA rating(s) are green whileTAK’s FA Score has 1 green FA rating(s).

  • RSCI’s FA Score: 0 green, 5 red.
  • TAK’s FA Score: 1 green, 4 red.
According to our system of comparison, both RSCI and TAK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TAK’s TA Score shows that 4 TA indicator(s) are bullish.

  • TAK’s TA Score: 4 bullish, 4 bearish.

Price Growth

RSCI (@Pharmaceuticals: Other) experienced а +3.70% price change this week, while TAK (@Pharmaceuticals: Other) price change was -0.23% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.23%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was -9.56%.

Reported Earning Dates

TAK is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RSCI YTD gains are higher at: 0.097 vs. TAK (-2.417).
RSCITAKRSCI / TAK
CapitalizationN/A43.1B-
EBITDAN/A1.01T-
Gain YTD0.097-2.417-4%
P/E RatioN/A36.79-
RevenueN/A4.17T-
Total CashN/A317B-
Total DebtN/A4.66T-
FUNDAMENTALS RATINGS
RSCI vs TAK: Fundamental Ratings
RSCI
TAK
OUTLOOK RATING
1..100
2213
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10083
PRICE GROWTH RATING
1..100
9772
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
2n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (5) in the Pharmaceuticals Major industry is somewhat better than the same rating for RSCI (40) in the null industry. This means that TAK’s stock grew somewhat faster than RSCI’s over the last 12 months.

TAK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as RSCI (100) in the null industry. This means that TAK’s stock grew similarly to RSCI’s over the last 12 months.

TAK's SMR Rating (83) in the Pharmaceuticals Major industry is in the same range as RSCI (100) in the null industry. This means that TAK’s stock grew similarly to RSCI’s over the last 12 months.

TAK's Price Growth Rating (72) in the Pharmaceuticals Major industry is in the same range as RSCI (97) in the null industry. This means that TAK’s stock grew similarly to RSCI’s over the last 12 months.

TAK's P/E Growth Rating (93) in the Pharmaceuticals Major industry is in the same range as RSCI (100) in the null industry. This means that TAK’s stock grew similarly to RSCI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TAK
RSI
ODDS (%)
Bullish Trend 5 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
46%
Momentum
ODDS (%)
Bearish Trend 5 days ago
57%
MACD
ODDS (%)
Bearish Trend 5 days ago
49%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
44%
Advances
ODDS (%)
Bullish Trend 5 days ago
44%
Declines
ODDS (%)
Bearish Trend 9 days ago
46%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
53%
Aroon
ODDS (%)
Bearish Trend 5 days ago
44%
View a ticker or compare two or three
Ad is loading...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

RSCI and

Correlation & Price change

A.I.dvisor tells us that RSCI and TAK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCI and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSCI
1D Price
Change %
RSCI100%
N/A
TAK - RSCI
24%
Poorly correlated
-1.00%
ETST - RSCI
22%
Poorly correlated
-9.00%
TEVJF - RSCI
5%
Poorly correlated
N/A
ROMJF - RSCI
5%
Poorly correlated
N/A
PCYN - RSCI
4%
Poorly correlated
N/A
More

TAK and

Correlation & Price change

A.I.dvisor tells us that TAK and ELAN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TAK and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-1.00%
ELAN - TAK
27%
Poorly correlated
+0.08%
RDY - TAK
25%
Poorly correlated
+0.47%
ZTS - TAK
24%
Poorly correlated
-2.05%
SNOA - TAK
24%
Poorly correlated
-0.38%
HLN - TAK
23%
Poorly correlated
+0.54%
More